Celsion Corp

Find Ratings Reports
CLSN : NASDAQ : Health Care
$1.56 | %
Today's Range: 1.52 - 1.56
Avg. Daily Volume: 568000.0
09/22/17 - 4:00 PM ET

Financial Analysis


CELSION CORP's gross profit margin for the second quarter of its fiscal year 2017 has significantly increased when compared to the same period a year ago. While net income decreased, sales have remained unchanged. CELSION CORP has weak liquidity. Currently, the Quick Ratio is 0.52 which shows a lack of ability to cover short-term cash needs. The company's liquidity has decreased from the same period last year.

At the same time, stockholders' equity ("net worth") has significantly decreased by 59.73% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is in a position in which financial difficulties could develop in the future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q2 FY17 Q2 FY16
Net Sales ($mil)0.130.13
EBITDA ($mil)0.00.0
EBIT ($mil)-4.57-4.74
Net Income ($mil)-4.89-4.53


Balance Sheet Q2 FY17 Q2 FY16
Cash & Equiv. ($mil)3.6314.47
Total Assets ($mil)29.6643.52
Total Debt ($mil)0.04.58
Equity ($mil)6.6516.51


Profitability Q2 FY17 Q2 FY16
Gross Profit Margin-3656.0-3792.8
EBITDA Margin0.00.0
Operating Margin-3656.0-3792.8
Sales Turnover0.020.01
Return on Assets-73.7-46.02
Return on Equity-328.72-121.29
Debt Q2 FY17 Q2 FY16
Current Ratio0.541.44
Debt/Capital0.00.22
Interest Expense0.030.2
Interest Coverage-152.33-23.24


Share Data Q2 FY17 Q2 FY16
Shares outstanding (mil)5.911.84
Div / share0.00.0
EPS-0.79-2.66
Book value / share1.128.97
Institutional Own % n/a n/a
Avg Daily Volume567824.01760417.0

Valuation


SELL. The current P/E ratio is negative, which has no meaningful value in the assessment of premium or discount valuation, it simply displays that the company has negative earnings. For additional comparison, its price-to-book ratio of 1.36 indicates a significant discount versus the S&P 500 average of 3.11 and a significant discount versus the industry average of 12.06. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. After reviewing these and other key valuation criteria, CELSION CORP proves to trade at a discount to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
CLSN NM Peers 39.29   CLSN NM Peers 27.33

Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.

CLSN's P/E is negative making this valuation measure meaningless.

 

Neutral. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

CLSN's P/CF is negative making the measure meaningless.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
CLSN NM Peers 25.51   CLSN NA Peers 0.49

Neutral. The absence of a valid price-to-projected earnings ratio happens when a stock can not be valued on the basis of a negative expected future earnings.

CLSN's ratio is negative making this valuation measure meaningless.

 

Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

Ratio not available.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
CLSN 1.36 Peers 12.06   CLSN 30.65 Peers 9.89

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

CLSN is trading at a significant discount to its peers.

 

Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

CLSN is expected to have an earnings growth rate that significantly exceeds its peers.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
CLSN 18.10 Peers 99.07   CLSN 0.00 Peers 241.27

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

CLSN is trading at a significant discount to its industry on this measurement.

 

Neutral. Comparing a company's sales growth to its industry helps to determine if the company is adding or losing market share.

The growth rate for CLSN is not available.

 

 

Latest Stock Upgrades/Downgrades